Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 11, 2004, Pages 4113-4119

  Kosowska, Klaudia ^a   Credito, Kim ^a   Pankuch, Glenn A ^a   Hoellman, Dianne ^a   Lin, Gengrong ^a   Clark, Catherine ^a   Dewasse, Bonifacio ^a   McGhee, Pamela ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; GW 708408; GW 773546; L22 PROTEIN; L4 PROTEIN; MACROLIDE; RIBOSOME PROTEIN; RNA 23S; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 23S; TIME FACTORS;

EID: 7244242375     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.11.4113-4119.2004     Document Type: Article

References (20)

1. Clark, C. L., B. Bozdogan, M. Peric, B. Dewasse, M. R. Jacobs, and P. C. Appelbaum. 2002. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. Antimicrob. Agents Chemother. 46:2956-2962.
2. Craig, W. A., and S. Gudmondsson. 1996. Postantibiotic effect, p. 265-329. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
3. Credito, K. L., G. Lin, G. A. Pankuch, S. Bajaksouzian, M. R. Jacobs, and P. C. Appelbaum. 2001. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents. Antimicrob. Agents Chemother. 45:67-72.
4. Dagan, R., C. E. Johnson, S. McLinn, N. Abughali, J. Feris, E. Leibovitz, D. J. Burch, and M. R. Jacobs. 2000. Bacteriological and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr. Infect. Dis. J. 19:95-104.
5. Dagan, R., E. Leibovitz, D. M. Fliss, A. Lieberman, M. R. Jacobs, W. Craig, and P. Yagupsky. 2000. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob. Agents Chemother. 44:43-50.
6. Davies, T. A., L. M. Kelly, D. B. Hoellman, L. M. Ednie, C. K. Clark, S. Bajaksouzian, M. R. Jacobs, and P. C. Appelbaum. 2000. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis. Antimicrob. Agents Chemother. 44:633-639.
7. Goldstein, F. W., M. E. Emiran, A. Coutrot, and J. F. Acar. 1990. Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae. J. Antimicrob. Chemother. 25(Suppl. A):25-28.
8. Jacobs, M. R. 2001. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin. Microbiol. Infect. 7:589-596.
9. Jacobs, M. R., S. Bajaksouzian, and P. C. Appelbaum. 2003. Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 gram-positive cocci. J. Antimicrob. Chemother. 52:809-812.
10. Jacobs, M. R., S. Bajaksouzian, A. Zilles, G. Lin, G. A. Pankuch, and P. C. Appelbaum. 1999. Susceptibilities of Streptococcus pneumonias and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 USA surveillance study. Antimicrob. Agents Chemother. 43:1901-1908.
11. Maskell, J. P., A. M. Sefton, and J. D. Williams. 1990. Comparative in-vitro activity of azithromycin and erythromycin against gram-positive cocci, Haemophilus influenzae and anaerobes. J. Antimicrob. Chemother. 25(Suppl. A):19-24.
12. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS publication M7-A6. National Committee for Clinical Laboratory Standards. Wayne, Pa.
13. Needham, C. A. 1988. Haemophilus influenzae antibiotic susceptibility. Clin. Microbiol. Rev. 1:218-227.
14. Neu, H. C. 1991. The development of macrolides: clarithromycin in perspective. J. Antimicrob. Chemother. 27(Suppl. A):1-17.
15. Neuhauser, M. M., J. L. Prause, L. H. Danziger, and S. L. Pendland. 2001. Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumonias and Haemophilus influenzae. Antimicrob. Agents Chemother. 45:3613-3615.
16. Pankuch, G. A., D. B. Hoellman, G. Lin, S. Bajaksouzian, M. R. Jacobs, and P. C. Appelbaum. 1998. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and Moraxella catarrhalis by MIC determination and time-kill assay. Antimicrob. Agents Chemother. 42:3032-3034.
17. Peric, M., B. Bozdogan, M. R. Jacobs, and P. C. Appelbaum. 2003. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob. Agents Chemother. 47:1017-1022.
18. Vester, B., and S. Douthwaite. 2001. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45:1-12.
19. Yeo, S. F., E. Akalin, S. Arikan, R. Auckenthaler, T. Bergan, K. Dornbusch, A. J. Howard, W. Hryniewicz, R. N. Jones, G. Koupari, N. J. Legakis, J. McLaughlin, O. Ozkuyumcu, A. Percival, I. Phillips, D. Reeves, R. Spencer, R. E. Warren, and J. D. Williams. 1996. Susceptibility testing of Haemophilus influenzae-an international collaborative study in quality assessment. J. Antimicrob. Chemother. 38:363-386.
20. Zeckel, M. L., K. D. Jacobson, F. J. Guerra, D. G. Therasse, and D. Farlow. 1992. Loracarbef (LY 163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis. Clin. Ther. 14:214-229.